Home›Stock Screener›RPG Life Sciences›Financial Statements

RPG Life Sciences Complete Financial Statements

12 Years of Data
2026 - 2015

In FY2026, RPG Life Sciences (RPGLIFE) reported revenue ₹190 Cr, net profit ₹30 Cr and EPS ₹18.08, with a net profit margin of 15.8% and ROE of 5.0%. Full financial statements from FY2015 to FY2026 (12 years) — income statement, balance sheet and cash flow in ₹ Crores. Download as Excel or CSV. Explore RPG Life Sciences intrinsic price to estimate fundamental worth using multiple valuation models.

Complete Financial Data Export

Profitability Ratios

Net Profit Margin 15.79% 2026 data
EBITDA Margin 24.21% 2026 data
Operating Margin 19.00% 2026 data
Return on Assets 3.78% 2026 data
Return on Equity 4.96% 2026 data

Balance Sheet Ratios

Current Ratio 19.44 2026 data
Equity Ratio 76.29% 2026 data
Asset Turnover 0.24 2026 data

RPGLIFE Revenue, Net Profit & EBITDA — Year-on-Year Growth

RPGLIFE YoY (Mar 2025 vs Mar 2026) — revenue -26.4%, net profit -74.4%, EBITDA -67.1%, expenses +22.0%. Review RPGLIFE PE ratio trends to evaluate earnings-based valuation against sector peers.

Revenue Growth
-26.4%
Year-over-Year
Net Profit Growth
-74.4%
Year-over-Year
EBITDA Growth
-67.1%
Year-over-Year
Expense Growth
+22.0%
Year-over-Year
Assets Growth
+20.5%
Year-over-Year
Equity Growth
+13.9%
Year-over-Year
Operating Cash Flow Growth
-17.0%
Year-over-Year
Investing Cash Flow Growth
+46.8%
Year-over-Year
Financing Cash Flow Growth
-35.0%
Year-over-Year

RPGLIFE Income Statement — Revenue, EBITDA & Net Profit

RPG Life Sciences revenue ₹190 Cr, EBITDA ₹46 Cr, net profit ₹30 Cr, EPS ₹18.08 (2026) — net profit margin 15.8%. For live price, earnings ratios and company overview, see RPG Life Sciences share price chart.

Periods ₹ Crores
Particulars Mar 2026 Sept 2025 Mar 2025 Jun 2025 Dec 2025 Dec 2024
Revenue 190 197 258 166 183 176
Expenses 144 143 118 125 149 124
EBITDA 46 55 140 41 35 53
Operating Profit Margin % 19.00% 21.00% 18.00% 26.00% 17.00% 28.00%
Depreciation 6 5 5 5 5 6
Interest 0 0 0 0 0 0
Profit Before Tax 40 50 135 35 29 47
Tax 10 13 18 9 7 12
Net Profit 30 37 117 26 22 35
Earnings Per Share (₹) 18.08 22.28 70.96 15.90 13.38 21.12

RPGLIFE Balance Sheet — Assets, Liabilities & Shareholders' Equity

RPGLIFE total assets ₹793 Cr, total equity ₹605 Cr, total liabilities ₹ Cr (2026) — ROE 5.0%.

Years Annual Data ₹ Crores
Particulars 2026 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
ASSETS
Total Assets 793 658 513 419 345 303 267 251 291 247 205 197
Current Assets 525 465 298 264 207 176 126 97 143 96 87 86
Fixed Assets 220 172 114 124 104 113 123 128 131 137 109 105
Capital Work in Progress 20 16 96 25 31 12 10 17 9 2 2 1
Investments 124 127 91 58 0 0 0 0 0 0 0 0
Other Assets 0 343 212 211 210 178 134 106 152 108 94 92
LIABILITIES
Total Liabilities
Current Liabilities 27 7 7 9 9 7 8 13 16 21 5 5
Non-Current Liabilities
SHAREHOLDERS' EQUITY
Total Equity 605 531 375 308 256 216 177 161 155 147 134 125
Share Capital 13 13 13 13 13 13 13 13 13 13 13 13
Reserves & Surplus 592 517 362 294 243 203 163 147 142 134 120 112

RPGLIFE Cash Flow Statement — Operating, Investing & Financing

RPG Life Sciences operating cash flow ₹78 Cr, investing ₹-42 Cr, financing ₹-27 Cr, net cash flow ₹9 Cr (2025).

Periods ₹ Crores
Particulars March 2025 March 2024 March 2023 March 2022 March 2021 March 2020 March 2019 March 2018 March 2017 March 2016 March 2015
Operating Activities 78 94 91 65 58 50 46 15 7 33 -2
Investing Activities -42 -79 -106 -35 -8 -11 -19 -16 -30 -15 -10
Financing Activities -27 -20 -17 -14 -11 -39 -27 0 23 -18 12
Net Cash Flow 9 -5 -32 17 40 0 0 -1 1 0 0